Research Analysts Set Expectations for RARE FY2027 Earnings

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) – Investment analysts at Wedbush reduced their FY2027 earnings per share estimates for shares of Ultragenyx Pharmaceutical in a note issued to investors on Wednesday, April 16th. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings of $1.04 per share for the year, down […]